Answers are grounded in this paper and cite their sources.
In this study, a low molecular weight peptides fraction (<3 kDa, named NJSP) was isolated and purified from the skin protein hydrolysate of Nibea japonica by ultrafiltration. The in vivo immunomodulatory effects of NJSP were investigated in cyclophosphamide (CY)-induced immunosuppressed mice. The intragastric administration of NJSP (100, 200, 400 mg/kg/d) upregulated the immune organ indexes, restored the pathological histomorphology of immune organs, and improved the body weight of CY-treated mice in a time and dose-dependent manner. NJSP treatment also remarkably promoted the proliferation of splenocyte, enhanced phagocytosis of macrophages, restored delayed-type hypersensitivity (DTH). Moreover, NJSP administration dramatically improved hemolysin, tumor necrosis factor α (TNF-α), immunoglobulin (Ig) A, IgG and IgM levels in blood serum in a dose-dependent manner. Besides, NJSP also significantly increased the activities of superoxidase dismutase (SOD) and catalase (CAT), improved the total antioxidant capacity (T-AOC), and decreased malondialdehyde (MDA) levels in blood serum. These findings confirm that NJSP can protect the immune system against oxidative damage to maintain homeostasis. Finally, NJSP can serve as a promising immunomodulator with potential application in functional food and nutraceutical industry.
No takes yet. Share an insight, caveat, or question.
Yu et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: